Associate Director of BioAnalytical Technology
Dr. Daniel Braas’ area of expertise is analytical chemistry and bioinformatics, with a focus on experimental design and analysis of mass spectrometry-based assays. He received degree in chemistry and molecular biology from the Westfälische Wilhelms-Universität Münster, Germany and did a postdoctoral fellowship at the University of California – Los Angeles (UCLA), studying chromatin modification in primary macrophages. A second postdoctoral fellowship in the Department of Molecular and Medical Pharmacology at UCLA attracted him to quantitative metabolomics analysis.
As Scientific Director and in collaboration with Dr. Thomas Graeber (Director), Dr. Braas established the UCLA Metabolomics Center, where he developed the experimental as well as bioinformatics pipelines to perform targeted and untargeted mass spectrometry-based metabolomics assays, including experiments using stable isotope tracing. In 2017, he became an Adjunct Assistant Professor in the Department of Molecular and Medical Pharmacology at UCLA. Dr. Braas joined Stemina Biomarker Discovery in 2018 to bring his expertise in mass spectrometry-based metabolomics to help identify the metabolic signatures of children with autism spectrum disorders (ASD).